Basic Search  |  Summaries  |  Advanced Search

Violation Tracker Industry Summary Page

Industry: pharmaceuticals
Penalty Total since 2000: $116,245,163,450
Number of Records: 1,270
Note: The totals include only those entries matched to a parent company. The industry designation is the primary one for the parent's operations overall. The totals are adjusted to account for the fact that each parent's entries may include both agency records and settlement announcements for the same case; or else a penalty covering multiple locations may be listed in the individual records for each of the facilities. They are also adjusted to reflect cases in which federal and state or local agencies cooperated and issued separate announcements of the outcome. Duplicate or overlapping penalty amounts are marked with an asterisk in the individual records list below.
Top 10 Current Parent CompaniesTotal Penalty $Number of Records
Johnson & Johnson$24,497,162,77088
Pfizer$10,948,368,52398
Merck$10,710,400,03189
Teva Pharmaceutical Industries$10,242,576,79696
GlaxoSmithKline$9,572,803,40650
Purdue Pharma$9,278,372,78711
AbbVie$7,560,456,40484
Takeda Pharmaceutical$3,987,516,44732
Endo International$3,311,990,66730
Eli Lilly$2,831,299,67626

Individual Penalty Records:

Click on the company or penalty amount for more information on each case. Click on the parent name to reach the summary page for that parent company.

Download results as CSV or XML or Save your search (Click here for information on download subscriptions)
CompanyCurrent ParentPrimary Offense TypeYearAgencyPenalty Amount sort icon
Schering-Plough CorporationMerckkickbacks and bribery2004DOJ_CIVIL$345,000,000
Pfizer Inc.Pfizerprice-fixing or anti-competitive practices2021private lawsuit-federal$345,000,000
Shire Pharmaceuticals LLCTakeda PharmaceuticalFalse Claims Act and related2017DOJ_CIVIL$350,000,000
AstraZeneca Pharmaceuticals LPAstraZenecaFalse Claims Act and related2003DOJ_CIVIL$354,900,000
Actelion Pharmaceuticals US, Inc.Johnson & JohnsonFalse Claims Act and related2018DOJ_CIVIL$360,000,000
Eli Lilly and CompanyEli Lillyoff-label or unapproved promotion of medical products2009MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $361,828,456
Wyeth Pharmaceuticals, Inc.PfizerFalse Claims Act and related2016MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $371,351,180
Indivior Inc.Indivior PLCprice-fixing or anti-competitive practices2024private lawsuit-federal$385,000,000
Janssen PharmaceuticalsJohnson & Johnsondrug or medical equipment safety violation2019private lawsuit-federal$387,500,000
Novartis PharmaceuticalsNovartiskickbacks and bribery2015USAO$390,000,000
Janssen Pharmaceuticals, Inc.Johnson & Johnsonoff-label or unapproved promotion of medical products2013USAO$410,000,000
Novartis Pharmaceuticals CorporationNovartisoff-label or unapproved promotion of medical products2010FDA$422,500,000
Cephalon IncTeva Pharmaceutical Industriesoff-label or unapproved promotion of medical products2008FDA$425,000,000
Warner-LambertPfizeroff-label or unapproved promotion of medical products2004FDA$430,000,000
Schering-Plough CorporationMerckoff-label or unapproved promotion of medical products2006USAO$435,000,000
Endo International plcEndo Internationaloff-label or unapproved promotion of medical products2022MULTI-AG$450,000,000
Endo Health Solutions Inc.Endo Internationaldrug or medical equipment safety violation2024DOJ_CIVIL$464,900,000
Mylan Inc.ViatrisFalse Claims Act and related2017DOJ_CIVIL$465,000,000
Mylan Inc.ViatrisFalse Claims Act and related2017MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $465,000,000
GlaxoSmithKlineGlaxoSmithKlineoff-label or unapproved promotion of medical products2012MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $477,792,391
Ranbaxy, Inc.Sun Pharmaceuticalsprice-fixing or anti-competitive practices2022private lawsuit-federal$485,000,000
Wyeth Pharmaceuticals Inc.Pfizeroff-label or unapproved promotion of medical products2013FDA$490,900,000
Ranbaxy USA Inc.Sun Pharmaceuticalsdrug or medical equipment safety violation2013FDA$500,000,000
Schering-Plough CorporationMerckdrug or medical equipment safety violation2002DOJ_CIVIL$500,000,000
Eli Lilly and CompanyEli Lillydrug or medical equipment safety violation2007private lawsuit-federal$500,000,000
Teva Pharmaceuticals USA Inc.Teva Pharmaceutical Industriesprice-fixing or anti-competitive practices2015private lawsuit-federal$512,000,000
Bristol-Myers Squibb CompanyBristol-Myers Squibboff-label or unapproved promotion of medical products2007DOJ_CIVIL$515,000,000
AstraZeneca LPAstraZenecaoff-label or unapproved promotion of medical products2010FDA$520,000,000
Johnson & JohnsonJohnson & Johnsonoff-label or unapproved promotion of medical products2013MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $541,000,000
Indivior SolutionsIndivior PLCFalse Claims Act and related2020DOJ_CIVIL$589,000,000
Allergan Inc.AbbVieoff-label or unapproved promotion of medical products2010FDA$600,000,000
Abbott Laboratories and CG NutritionalsAbbott LaboratoriesFalse Claims Act and related2003DOJ_CIVIL$600,000,000
Purdue Frederick Company Inc.Purdue PharmaFalse Claims Act and related2007USAO$600,000,000
Amgen Inc.Amgenoff-label or unapproved promotion of medical products2012MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $612,000,000
Novartis Pharmaceuticals CorporationNovartisFalse Claims Act and related2020DOJ_CIVIL(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $642,000,000
Merck & CompanyMerckFalse Claims Act and related2008DOJ_CIVIL$650,000,000
Boehringer Ingelheim InternationalBoehringer Ingelheimdrug or medical equipment safety violation2014private lawsuit-federal$650,000,000
Eli Lilly and CompanyEli Lillydrug or medical equipment safety violation2005private lawsuit-federal$690,000,000
Serono, S.A.Merck KGaA (EMD)off-label or unapproved promotion of medical products2005FDA$704,000,000
PfizerPfizerdrug or medical equipment safety violation2008private lawsuit-federal$745,000,000
SB Pharmco Puerto Rico Inc.GlaxoSmithKlinedrug or medical equipment safety violation2010FDA$750,000,000
PfizerPfizerdrug or medical equipment safety violation2004private lawsuit-federal$750,000,000
Forest Laboratories LLCAbbVieprice-fixing or anti-competitive practices2020private lawsuit-federal$750,000,000
Amgen Inc.Amgenoff-label or unapproved promotion of medical products2012FDA$762,000,000
GlaxoSmithKlineGlaxoSmithKlinedrug or medical equipment safety violation2010private lawsuit-federal$770,000,000
Endo International PLCEndo Internationaldrug or medical equipment safety violation2017private lawsuit-federal$775,000,000
Pfizer Inc.PfizerFalse Claims Act and related2016DOJ_CIVIL$784,600,000
Endo International PLCEndo Internationaldrug or medical equipment safety violation2014private lawsuit-federal$830,000,000
TAP Pharmaceutical Products Inc.Takeda PharmaceuticalFalse Claims Act and related2001DOJ_CIVIL$875,000,000
Biogen Inc.BiogenFalse Claims Act and related2022DOJ_CIVIL$900,000,000
Merck, Sharp & DohmeMerckoff-label or unapproved promotion of medical products2011FDA$950,000,000
Cephalon, Inc.Teva Pharmaceutical Industriesprice-fixing or anti-competitive practices2015FTC$1,200,000,000
Eli Lilly and CompanyEli Lillyoff-label or unapproved promotion of medical products2009FDA$1,415,000,000
Abbott Laboratories Inc.AbbVieoff-label or unapproved promotion of medical products2012FDA$1,500,000,000
MallinckrodtMallinckrodtControlled Substances Act violation2020MULTI-AG$1,600,000,000
Johnson & JohnsonJohnson & Johnsonoff-label or unapproved promotion of medical products2013FDA$2,200,000,000
Pfizer Inc.Pfizeroff-label or unapproved promotion of medical products2009FDA$2,300,000,000
Merck & Co., Inc.Mercktax violations2007IRS$2,300,000,000
AllerganAbbVieoff-label or unapproved promotion of medical products2022MULTI-AG$2,370,000,000
Takeda Pharmaceutical Co. Ltd.Takeda Pharmaceuticaldrug or medical equipment safety violation2015private lawsuit-federal$2,400,000,000
DePuy Orthopaedics, Inc.Johnson & Johnsondrug or medical equipment safety violation2013private lawsuit-federal$2,475,000,000
Johnson & JohnsonJohnson & Johnsonproduct safety violation2021private lawsuit-federal$2,500,000,000
GlaxoSmithKline LLCGlaxoSmithKlineoff-label or unapproved promotion of medical products2012FDA$3,000,000,000
GlaxoSmithKline Holdings (Americas)GlaxoSmithKlinetax violations2006IRS$3,400,000,000
American Home ProductsPfizerdrug or medical equipment safety violation2002private lawsuit-federal$3,750,000,000
Teva PharmaceuticalsTeva Pharmaceutical Industriesoff-label or unapproved promotion of medical products2022MULTI-AG$4,250,000,000
Merck & Co.Merckdrug or medical equipment safety violation2007private lawsuit-federal$4,850,000,000
Johnson & JohnsonJohnson & Johnsonoff-label or unapproved promotion of medical products2021MULTI-AG$5,000,000,000
Purdue Pharma LPPurdue Pharmafraud2020DOJ_CIVIL$8,344,000,000
Johnson & JohnsonJohnson & Johnsonproduct safety violation2023private lawsuit-federal$8,900,000,000
(*): Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting.